Droia Ventures: Specialist investor in drug development firms, accelerating novel science for patient impact.
Location
Luxembourg, Luxembourg Canton, LU
Founded
2011
Droia Ventures is a specialist investor focused on drug development companies, particularly those advancing novel science and innovative approaches to bring promising drug candidates to patients. They typically invest in early to mid-stage rounds, including Seed, Series A, Series B, and Series C, with a strong emphasis on accelerating the clinical progress of young drug development firms.
Notable portfolio companies include Accent Therapeutics, Actio Biosciences, and Arcus Biosciences. Droia Ventures is led by key partners who bring extensive experience in the biotech sector. The firm offers unique value-add services such as strategic guidance and operational support to help portfolio companies navigate the complexities of drug development and achieve clinical milestones efficiently.
Droia Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
